Director of Resmed board resigns
Tuesday, 10 June, 2008
A director of the Resmed (ASX: RMD) board has resigned, reducing the number of board members to eight.
Donagh McCarthy, president of the renal division of Baxter Healthcare in the US, has declined to stand for re-election to the board.
The remaining board members decided that instead of finding a replacement for McCarthy, the board would be reduced to eight.
Resmed founder Dr Peter Farrell will continue to hold the post of executive director of the board.
Farrell had previously arranged to become non-executive chairman by June 30.
Liquid fat treatment provides hope for rare childhood disease
A liquid fat supplement, triheptanoin, can reverse mitochondrial dysfunction and cell death in...
NSW Govt delivers foot-and-mouth vaccine to protect livestock
A biodegradable vaccine to protect livestock from foot-and-mouth disease has been developed as...
Scientists optimise delivery of mRNA to target cells
A highly versatile new method captures and attaches antibodies to the surface of mRNA-loaded...
